M&A
confidence high
sentiment positive
materiality 0.75
Vireo Growth to acquire C21 Investments in all-stock deal; exchange ratio 0.023052
Vireo Growth Inc.
- Each C21 share exchanged for 0.023052 Vireo subordinate voting shares; C21 shareholders to vote in Q3 2026.
- Acquisition adds ~15 Nevada dispensaries and 158,000 sq ft of cultivation/manufacturing capacity.
- Termination fee of $3M payable by C21 in certain circumstances; outside date May 31, 2027.
- Transaction requires C21 shareholder approval (2/3 majority), court orders, and regulatory approvals.
- C21 board and special committee unanimously recommend deal; Needham & Co. provided fairness opinion.